4
Changes in Ownership
Korro Bio, Inc. Filed Acc 0001127602-21-002022
Options or other derivatives
- Chief Scientific Officer acquired 70,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Loose Christopher R. · Chief Scientific Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-01-15 | Grant or award : show line 1 in the form Stock Option | +70,000 | $35.85 | 2031-01-14 | 70,000 | 70,000 | D |
Loading xslF345X03/form4.xml…